Article Sidebar

PDF
Date Published: 06/04/2026
Abstract Views: 103
Views PDF: 37
DOI: https://doi.org/10.51298/vmj.v560i2.17881
Issue
Vol. 560 No. 2 (2026)
Section
Các bài báo
How to Cite
Bùi , V. C., Đỗ , N. S., Đặng, Q. T., Võ, Q. T., Trần, H. T., & Nguyễn , V. T. (2026). PROGNOSTIC FACTORS ASSOCIATED WITH THE SUCCESS OF EXTRACORPOREAL CARBON DIOXIDE REMOVAL IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME. Vietnam Medical Journal, 560(2). https://doi.org/10.51298/vmj.v560i2.17881

PROGNOSTIC FACTORS ASSOCIATED WITH THE SUCCESS OF EXTRACORPOREAL CARBON DIOXIDE REMOVAL IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME

Văn Cường Bùi , Ngọc Sơn Đỗ , Quốc Tuấn Đặng, Quang Trung Võ, Hữu Thông Trần, Văn Trọng Nguyễn

Main Article Content

Abstract

Objective: To identify prognostic factors associated with the success of extracorporeal carbon dioxide removal (ECCO₂R) in patients with acute respiratory distress syndrome (ARDS). Subjects: ARDS patients indicated for ECCO₂R the Center for Critical Care Medicine – Bach Mai Hospital from July 2024 to September 2025. Methods: A retrospective descriptive observational study with convenient sampling included all ARDS patients who underwent ECCO₂R during the study period; data were collected from medical records and case report forms and analyzed using SPSS. Results: A total of 15 patients with ARDS were enrolled in this study, the majority were male, with a mean age of 58,5 ± 15,1 years and a mean SOFA score of 9; 66,7% required norepinephrine support. Univariate logistic regression analysis revealed no factor reaching statistical significance; however, a favorable trend was observed in patients with a higher ventilatory ratio (VR, OR = 3,106; p = 0,145). Unfavorable factors included older age (OR = 0,24; p = 0,14), the presence of comorbidities (OR = 0,71; p = 0,55), and higher SOFA scores (OR = 0,65; p = 0,27). Conclusion: In patients with ARDS undergoing ECCO₂R, a higher VR was associated with a trend toward greater clinical success, whereas advanced age, comorbidities, and higher SOFA scores were unfavorable factors.

Article Details

Keywords

ECCO₂R; ARDS; hemodynamics; ventilatory ratio; prognostic factors

References

1. Lamas T, Del Sorbo L, Fan E. Recent advances and future directions in extracorporeal carbon dioxide removal. J Clin Med. 2025; 14(1):12. doi: 10.3390/jcm14010012.
2. Vito Fanelli, Marco V. Ranieri, Jordi Mancebo, et al. Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate ARDS. Critical Care. 2016;20:36. doi:10.1186/s13054-016-1211-y.
3. Combes A, Fanelli V, Pham T, Ranieri VM; for the SUPERNOVA investigators. Feasibility and safety of extracorporeal CO₂ removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Med. 2019;45(5):592-600. doi:10.1007/s00134-019-05567-4.
4. Bein T, Weber-Carstens S, Goldmann A, et al. Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO₂ removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study.Intensive Care Med.2013;39 (5):847-856.doi:10.1007/s00134-012-2787-6.
5. McNamee JJ, Gillies MA, Barrett NA, et al. Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial. JAMA. 2021; 326(11):1013-1023. doi: 10.1001/ jama.2021.13374.
6. Elie Azoulay, Virginie Lemiale, Bruno Mourvillier, et al. Management and outcomes of acute respiratory distress syndrome patients with and without comorbid conditions. Intensive Care Med. 2018; 44(7):1050–1060. doi: 10.1007/ s00134-018-5209-6.
7. Goligher EC, Combes A, et al. Determinants of the effect of extracorporeal carbon dioxide removal in the SUPERNOVA trial: implications for trial design. Intensive Care Med. 2019;45(9): 1219–1230.